CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 100.0%

Compliant submissions 1

Incompliant submissions 0

Total trials 1

My Organizations' Clinical Trials

Showing 1425 of 3173 entries

View as:

Bioequivalence Study for Crizotinib Encapsulated Microsphere Formulation (eMS)

Phase: N/A Priority: Normal

NCT ID: NCT04856293 Org: User:

Start: 04/16/21 End: 12/15/21 Due: 12/15/22

A Phase I Study To Estimate The Effect Of Ketoconazole And Omeprazole On The Pharmacokinetics Of Dimebon In Healthy Subjects Who Are Normal Or Poor CYP2D6 Metabolizers

Phase: N/A Priority: Normal

NCT ID: NCT00931073 Org: User:

Start: 07/31/09 End: 10/31/09 Due: 10/31/10

Evaluation of a Single Vaccination With a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years

Phase: N/A Priority: Normal

NCT ID: NCT02364596 Org: User:

Start: 01/31/15 End: 02/28/15 Due: 02/28/16

A Study To Assess The Safety, Tolerability And Pharmacokinetics Of PF-06282999 Administered Orally In Healthy Adult Subjects

Phase: N/A Priority: Normal

NCT ID: NCT01626976 Org: User:

Start: 06/30/12 End: 03/31/13 Due: 03/31/14

Multiple Dose Dental Pain Study Of Ibuprofen Extended Release

Phase: N/A Priority: Normal

NCT ID: NCT01266161 Org: User:

Start: 11/22/10 End: 03/31/11 Due: 03/31/12

Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Subjects With A Genetic Cholesterol Disorder.

Phase: N/A Priority: Normal

NCT ID: NCT00145431 Org: User:

Start: 03/31/05 End: 12/31/06 Due: 12/31/07

Large Simple Trial (LST) Of Cardiovascular Safety Of Ziprasidone And Olanzapine- (Zodiac)

Phase: N/A Priority: Normal

NCT ID: NCT00418171 Org: User:

Start: 02/28/02 End: 04/30/07 Due: 04/30/08

A Study to Understand the Effect and Safety of the Study Medicine PF-07817883 in Adults Who Have Symptoms of COVID-19 But Are Not Hospitalized

Phase: N/A Priority: Normal

NCT ID: NCT05799495 Org: User:

Start: 05/23/23 End: 10/11/23 Due: 10/11/24

Plant Cell Expressed Recombinant Human Glucocerebrosidase Extension Trial

Phase: N/A Priority: Normal

NCT ID: NCT00705939 Org: User:

Start: 06/30/08 End: 08/31/13 Due: 08/31/14

A Study Of Early Markers Of Choroidal Neovascularization

Phase: N/A Priority: Normal

NCT ID: NCT00902785 Org: User:

Start: 03/31/08 End: 05/31/10 Due: 05/31/11

6-Month Open-Label Safety Study Of PD 0332334 In Elderly Patients With Generalized Anxiety Disorder (GAD)

Phase: N/A Priority: Normal

NCT ID: NCT00738738 Org: User:

Start: 01/31/09 End: 02/28/09 Due: 02/28/10

Study Evaluating a 13-valent Pneumococcal Conjugate Vaccine in Preterm Compared to Term Infants.

Phase: N/A Priority: Normal

NCT ID: NCT01193335 Org: User:

Start: 10/31/10 End: 01/31/14 Due: 01/31/15

A Multiple Dose Study Of PF-04950615 (RN316) In Subjects On Maximum Doses Of Statins

Phase: N/A Priority: Normal

NCT ID: NCT01350141 Org: User:

Start: 06/30/11 End: 06/30/12 Due: 06/30/13

Study of PF-07263689 in Participants With Selected Advanced Solid Tumors

Phase: N/A Priority: Normal

NCT ID: NCT05061537 Org: User:

Start: 10/20/21 End: 10/14/22 Due: 10/14/23

Efficacy and Safety of Tofacitinib in Subjects With Active Ankylosing Spondylitis (AS)

Phase: N/A Priority: Normal

NCT ID: NCT03502616 Org: User:

Start: 06/07/18 End: 08/20/20 Due: 08/20/21

Assessment of the Analgesic Effects of PF-06372865 in Healthy Volunteers Using Evoked Pain Endpoints

Phase: N/A Priority: Normal

NCT ID: NCT02238717 Org: User:

Start: 09/30/14 End: 11/30/14 Due: 11/30/15

Study Evaluating A Novel Ibuprofen Formulation In The Treatment Of Dental Pain

Phase: N/A Priority: Normal

NCT ID: NCT01216163 Org: User:

Start: 10/31/10 End: 01/31/11 Due: 01/31/12

Characterize Patients With Moderately Active Rheumatoid Arthritis (RA)

Phase: N/A Priority: Normal

NCT ID: NCT01557322 Org: User:

Start: 10/31/11 End: 09/30/12 Due: 09/30/13

Ibuprofen 5% Topical Gel CIPT

Phase: N/A Priority: Normal

NCT ID: NCT01771822 Org: User:

Start: 01/31/13 End: 02/28/13 Due: 02/28/14

Clinical Outcomes of Methicillin Resistant Staphylococcus Aureus (MRSA) Hospital-Based Pneumonia

Phase: N/A Priority: Normal

NCT ID: NCT01819935 Org: User:

Start: 12/31/12 End: 01/31/13 Due: 01/31/14

Clostridium Difficile Vaccine Efficacy Trial

Phase: N/A Priority: Normal

NCT ID: NCT03090191 Org: User:

Start: 03/29/17 End: 12/21/21 Due: 12/21/22

Study Evaluating Predictors of Response in Patients With Ankylosing Spondylitis

Phase: N/A Priority: Normal

NCT ID: NCT00900796 Org: User:

Start: 03/31/09 End: 05/31/11 Due: 05/31/12

A Trial Of Azithromycin SR For The Treatment Of Mild To Moderate Community Acquired Pneumonia In Japanese Adults

Phase: N/A Priority: Normal

NCT ID: NCT00360295 Org: User:

Start: 09/30/06 End: 05/31/07 Due: 05/31/08

A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal Cancer

Phase: N/A Priority: Normal

NCT ID: NCT05217446 Org: User:

Start: 07/11/22 End: 03/28/27 Due: 03/28/28

A Study To Observe Safety And Concentrations Of PF-05297909 And Proteins In Both Blood And Cerebrospinal Fluid After A Single Dose Of PF-05297909 In Healthy Adults

Phase: N/A Priority: Normal

NCT ID: NCT01462851 Org: User:

Start: 09/30/11 End: 02/29/12 Due: 02/28/13

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Bioequivalence Study for Crizotinib Encapsulated Microsphere Formulation (eMS)	NCT04856293	Pfizer	user2@example.com	None	2021-04-16	2021-12-15	2022-12-15	-	-	2025-07-14
A Phase I Study To Estimate The Effect Of Ketoconazole And Omeprazole On The Pharmacokinetics Of Dimebon In Healthy Subjects Who Are Normal Or Poor CYP2D6 Metabolizers	NCT00931073	Pfizer	user2@example.com	None	2009-07-31	2009-10-31	2010-10-31	-	-	2025-07-14
Evaluation of a Single Vaccination With a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years	NCT02364596	Pfizer	user2@example.com	None	2015-01-31	2015-02-28	2016-02-28	-	-	2025-07-14
A Study To Assess The Safety, Tolerability And Pharmacokinetics Of PF-06282999 Administered Orally In Healthy Adult Subjects	NCT01626976	Pfizer	user2@example.com	None	2012-06-30	2013-03-31	2014-03-31	-	-	2025-07-14
Multiple Dose Dental Pain Study Of Ibuprofen Extended Release	NCT01266161	Pfizer	user2@example.com	None	2010-11-22	2011-03-31	2012-03-31	-	-	2025-07-14
Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Subjects With A Genetic Cholesterol Disorder.	NCT00145431	Pfizer	user2@example.com	None	2005-03-31	2006-12-31	2007-12-31	-	-	2025-07-14
Large Simple Trial (LST) Of Cardiovascular Safety Of Ziprasidone And Olanzapine- (Zodiac)	NCT00418171	Pfizer	user2@example.com	None	2002-02-28	2007-04-30	2008-04-30	-	-	2025-07-14
A Study to Understand the Effect and Safety of the Study Medicine PF-07817883 in Adults Who Have Symptoms of COVID-19 But Are Not Hospitalized	NCT05799495	Pfizer	user2@example.com	None	2023-05-23	2023-10-11	2024-10-11	-	-	2025-07-14
Plant Cell Expressed Recombinant Human Glucocerebrosidase Extension Trial	NCT00705939	Pfizer	user2@example.com	None	2008-06-30	2013-08-31	2014-08-31	-	-	2025-07-14
A Study Of Early Markers Of Choroidal Neovascularization	NCT00902785	Pfizer	user2@example.com	None	2008-03-31	2010-05-31	2011-05-31	-	-	2025-07-14
6-Month Open-Label Safety Study Of PD 0332334 In Elderly Patients With Generalized Anxiety Disorder (GAD)	NCT00738738	Pfizer	user2@example.com	None	2009-01-31	2009-02-28	2010-02-28	-	-	2025-07-14
Study Evaluating a 13-valent Pneumococcal Conjugate Vaccine in Preterm Compared to Term Infants.	NCT01193335	Pfizer	user2@example.com	None	2010-10-31	2014-01-31	2015-01-31	-	-	2025-07-14
A Multiple Dose Study Of PF-04950615 (RN316) In Subjects On Maximum Doses Of Statins	NCT01350141	Pfizer	user2@example.com	None	2011-06-30	2012-06-30	2013-06-30	-	-	2025-07-14
Study of PF-07263689 in Participants With Selected Advanced Solid Tumors	NCT05061537	Pfizer	user2@example.com	None	2021-10-20	2022-10-14	2023-10-14	-	-	2025-07-14
Efficacy and Safety of Tofacitinib in Subjects With Active Ankylosing Spondylitis (AS)	NCT03502616	Pfizer	user2@example.com	None	2018-06-07	2020-08-20	2021-08-20	-	-	2025-07-14
Assessment of the Analgesic Effects of PF-06372865 in Healthy Volunteers Using Evoked Pain Endpoints	NCT02238717	Pfizer	user2@example.com	None	2014-09-30	2014-11-30	2015-11-30	-	-	2025-07-14
Study Evaluating A Novel Ibuprofen Formulation In The Treatment Of Dental Pain	NCT01216163	Pfizer	user2@example.com	None	2010-10-31	2011-01-31	2012-01-31	-	-	2025-07-14
Characterize Patients With Moderately Active Rheumatoid Arthritis (RA)	NCT01557322	Pfizer	user2@example.com	None	2011-10-31	2012-09-30	2013-09-30	-	-	2025-07-14
Ibuprofen 5% Topical Gel CIPT	NCT01771822	Pfizer	user2@example.com	None	2013-01-31	2013-02-28	2014-02-28	-	-	2025-07-14
Clinical Outcomes of Methicillin Resistant Staphylococcus Aureus (MRSA) Hospital-Based Pneumonia	NCT01819935	Pfizer	user2@example.com	None	2012-12-31	2013-01-31	2014-01-31	-	-	2025-07-14
Clostridium Difficile Vaccine Efficacy Trial	NCT03090191	Pfizer	user2@example.com	None	2017-03-29	2021-12-21	2022-12-21	-	-	2025-07-14
Study Evaluating Predictors of Response in Patients With Ankylosing Spondylitis	NCT00900796	Pfizer	user2@example.com	None	2009-03-31	2011-05-31	2012-05-31	-	-	2025-07-14
A Trial Of Azithromycin SR For The Treatment Of Mild To Moderate Community Acquired Pneumonia In Japanese Adults	NCT00360295	Pfizer	user2@example.com	None	2006-09-30	2007-05-31	2008-05-31	-	-	2025-07-14
A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal Cancer	NCT05217446	Pfizer	user2@example.com	None	2022-07-11	2027-03-28	2028-03-28	-	-	2025-07-14
A Study To Observe Safety And Concentrations Of PF-05297909 And Proteins In Both Blood And Cerebrospinal Fluid After A Single Dose Of PF-05297909 In Healthy Adults	NCT01462851	Pfizer	user2@example.com	None	2011-09-30	2012-02-29	2013-02-28	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance